Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Fuji
Farmers Insurance
Moodys
McKesson
Express Scripts
Colorcon
Johnson and Johnson

Generated: April 23, 2018

DrugPatentWatch Database Preview

TENORMIN Drug Profile

« Back to Dashboard

When do Tenormin patents expire, and when can generic versions of Tenormin launch?

Tenormin is a drug marketed by Astrazeneca and Alvogen Malta and is included in two NDAs.

The generic ingredient in TENORMIN is atenolol. There are thirty-three drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the atenolol profile page.
Drug patent expirations by year for TENORMIN
Pharmacology for TENORMIN
Synonyms for TENORMIN
( inverted question mark)-Atenolol
(?)-Atenolol
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
(+-)-Atenolol
(+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(+/-)-4-(2-Hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide
(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(+/-)-Atenolol
(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
(A+/-)-Atenolol
(inverted question mark)-Atenolol
(r,s)-atenolol
(RS)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(RS)-Atenolol
(y)-Atenolol
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
106020-65-9
122A687
2-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid
2-(4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl)acetamide
2-(4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenyl)acetamide
2-(4-{2-hydroxy-3-[(methylethyl)amino]propoxy}phenyl)acetamide
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide
2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide
2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide
2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]-phenyl}acetamide
2-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide
2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
29122-68-7
3B1-006626
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide
4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide
60966-51-0
A 7655
AB00052208_16
AB00052208-13
AB00052208-15
AB0011597
AC-8245
AC1L1D99
AC1Q1QBX
Acetamide, 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-
Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)
Aircrit
AK-88721
AKOS005111050
Alinor
Altol
AN-7253
Anselol
Antipressan
ANW-45215
API0001553
Apo-Atenolol
ARONIS23884
Artrenolol
Atcard
Atcardil
Atecard
Atehexal
Atenblock
Atendol
Atenet
Ateni
Atenil
Atenol
Atenol 1A pharma
Atenol acis
Atenol AL
Atenol Atid
Atenol Cophar
Atenol ct
Atenol Fecofar
Atenol Gador
Atenol Genericon
Atenol GNR
Atenol Heumann
Atenol MSD
Atenol NM Pharma
Atenol Nordic
Atenol PB
Atenol Quesada
Atenol Stada
Atenol Tika
Atenol Trom
Atenol von ct
Atenol-Mepha
Atenol-ratiopharm
Atenol-Wolff
Atenolin
atenolol
Atenolol (JAN/USP)
Atenolol (JP15/USP/INN)
Atenolol (JP17/USP/INN)
Atenolol [USAN:BAN:INN:JAN]
Atenolol [USAN:INN:BAN:JAN]
Atenolol [USAN:USP:INN:BAN:JAN]
Atenolol 1.0 mg/ml in Acetonitrile
Atenolol Bp
Atenolol, >=98% (TLC), powder
Atenolol, analytical reference material
Atenolol, European Pharmacopoeia (EP) Reference Standard
Atenolol, Pharmaceutical Secondary Standard; Certified Reference Material
Atenolol, United States Pharmacopeia (USP) Reference Standard
Atenololum
Atenololum [INN-Latin]
Atenomel
Atereal
Aterol
AX8005715
BB_SC-01519
BB_SC-1519
BBC/163
BBL009276
BC201805
BDBM25753
Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-
BENZENEACETAMIDE, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-, (+-)-
Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-
benzeneacetamide, 4-[2'-hydroxy-3;-[(1-methylethyl)amino]propoxy]-
Betablok
Betacard
Betasyn
Betatop Ge
BG0049
BIM-0050109.0001
Blocotenol
Blokium
BRD-A20239487-001-02-5
BRN 2739235
BSPBio_002915
CA0145
Cardaxen
Cardiopress
CAS-29122-68-7
CCG-39010
CCRIS 4196
CHEBI:2904
CHEMBL24
Corotenol
CPD000036768
CS-2927
CTK3J2163
Cuxanorm
D00235
D01UXC
DB00335
DivK1c_000057
dl-Atenolol
DR000815
DSSTox_CID_2628
DSSTox_GSID_22628
DSSTox_RID_76663
DTXSID2022628
Duraatenolol
duratenol
EINECS 249-451-7
EINECS 262-544-7
EN300-119532
EU-0100121
Evitocor
Farnormin
Felo-Bits
FT-0622499
FT-0693045
GEO-03413
GTPL548
Hipres
HMS1569L13
HMS1921H09
HMS2090I19
HMS2092D19
HMS2233E06
HMS3259K08
HMS3260I04
HMS3266K13
HMS3369B14
HMS3369D20
HMS3369P20
HMS500C19
HSDB 6526
HY-17498
Hypoten
I01-3572
Ibinolo
ICI 66,082
ICI 66082
ICI-66082
IDI1_000057
InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
Internolol
J10009
Jenatenol
Juvental
KB-222053
KB-47450
KB-62479
KBio1_000057
KBio2_001844
KBio2_004412
KBio2_006980
KBio3_002415
KBioGR_000790
KBioSS_001844
KS-00000XIG
KS-000046IQ
KS-5341
KSC492C6H
L000116
Lo-ten
Lopac0_000121
Loten
Lotenal
LP00121
LS-28557
LS-9707
MCULE-9148694071
METKIMKYRPQLGS-UHFFFAOYSA-
METKIMKYRPQLGS-UHFFFAOYSA-N
MFCD00057645
MLS000069622
MLS001066372
MLS001074163
MLS001304038
MolPort-001-792-717
MRF-0000571
Myocord
NC00548
NCGC00015007-06
NCGC00015007-07
NCGC00015007-08
NCGC00015007-09
NCGC00015007-10
NCGC00015007-11
NCGC00015007-13
NCGC00024566-03
NCGC00024566-04
NCGC00024566-05
NCGC00024566-06
NCGC00024566-07
NCGC00255122-01
NCGC00260806-01
Neatenol
NINDS_000057
Normalol
Normiten
Noten
NSC-757832
NSC757832
Opera_ID_1283
Oprea1_448775
OR108794
OR294583
Oraday
Ormidol
Panapres
Pharmakon1600-01501127
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
Q-200656
RTR-012731
SAM002564193
SBB056998
SBI-0050109.P003
SC-19545
Scheinpharm Atenol
SCHEMBL4362
Seles beta
Selobloc
Serten
Servitenol
SMR000036768
SPBio_001482
Spectrum_001364
SPECTRUM1501127
Spectrum2_001411
Spectrum3_001448
Spectrum4_000435
Spectrum5_001509
SR-01000000159
SR-01000000159-2
ST024754
ST2403914
Stermin
STK528649
Tenidon
Teno-basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic (Salt/Mix)
Tenormin (TN)
Tenormine
Tenormine [French]
Tensimin
Tensotin
Tox21_302426
Tox21_500121
TR-012731
Tredol
Unibloc
Uniloc
Vascoten
Vericordin
Wesipin
Xaten
Z-0828
Z1541638518
ZX-AS004380

US Patents and Regulatory Information for TENORMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca TENORMIN atenolol INJECTABLE;INJECTION 019058-001 Sep 13, 1989 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TENORMIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Healthtrust
McKesson
Teva
Medtronic
Moodys
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.